Articles
-
1 month ago |
tandfonline.com | Apar Kishor Ganti |Ralph B. D’Agostino |Victoria Allan |Patricia Prince
ABSTRACTAim Assess real-world outcomes of lurbinectedin and other second-line treatments (OST) in adults with small cell lung cancer that progressed on/after chemotherapy. Patients & methods US-based electronic medical data from Flatiron Health (01/01/2013–03/31/2022) were used. Baseline characteristics, including chemotherapy-free interval (CTFI), in patients receiving lurbinectedin or OST were balanced using propensity score (PS) overlap weighting.
-
1 month ago |
preprints.org | GAURAV KUMAR |Priyanka Chaudhary |Apar Kishor Ganti |Jungyoon Kim
Choose an area of interest and we will send you notifications of new preprints at your preferred frequency.
-
Dec 5, 2024 |
cancernetwork.com | Robin R. High |Apar Kishor Ganti |Alissa Marr |Clayton K. Oakley |Amulya Yellala |Sunil Tulpule
December 5, 2024By OncologyONCOLOGY Vol 38, Issue 12Pages: 462-468These data support less restrictive clinical trial eligibility criteria for those with metastatic NSCLC. This is especially true regarding both targeted therapy and immunotherapy treatment regimens. AbstractIntroduction: There are limited data available regarding patient outcomes in those who would have been ineligible to receive therapy based on the original clinical trial eligibility criteria.
-
Jul 5, 2023 |
mdedge.com | Apar Kishor Ganti
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 259
- Tweets
- 1K
- DMs Open
- No
RT @DrSanjayPopat: CM816 final OS at 5yr: HR=0.72, 65 vs 55% OS rate, significant Benefit consistent across stage and more for PDL1+; arg…
RT @BalazsHalmosMD: Robust OS benefit overall from just 3 rounds of neoadj chemo-IO for resectable st 1b-3a NSCLC with unprecedented OS for…
RT @DrRiyazShah: Immunotherapy time of day study; RANDOMISED; 1500hr cut off; massive PFS benefit ; massive OS benefit. #ASCO25 @BTOGORG #L…